Spero Therapeutics Inc. (SPRO) Fundamentals

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate, being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.
SHARE INFORMATION
Market Cap$ 70,134,954
Shares Outstanding35,067,477
Float29,760,209
Percent Float84.87%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 18,256,000
Latest Fiscal EPS$ -2.91
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions227
Institutional Holdings Date2022-09-30
Institutional Bought Previous 3 Months4,583,773
Institutional Holdings Percent65.5%
Institutional Sold Previous 3 Months4,556,493
Insider Holdings Date2022-09-30
Insider Bought Previous 3 Months315,000
Insider Holdings Percent2.7
Insider Sold Previous 3 Months1,907,813
Insider Shares Owned933,227
TRADING INFO
52 Week High$ 18.84
52 Week Low$ 0.68
52 Week High Change$ -88.94
21 Day Moving Average$ 1.4622
21 Day Extended Moving Average$ 1.5684
50 Day Moving Average$ 1.1024
50 Day Extended Moving Average$ 1.3565
200 Day Moving Average$ 5.1321
200 Day Extended Moving Average$ 4.7346
10 Day Average Volume30,966,541
20 Day Average Volume19,373,809
30 Day Average Volume15,631,904
50 Day Average Volume9,484,459
Alpha0.004071
Beta0.8133
Standard Deviation0.299151
R20.020713
7 Day Price Change$ -0.02
7 Day Percent Change-0.99%
21 Day Price Change$ 0.96
21 Day Percent Change92.31%
30 Day Price Change$ 1.27
30 Day Percent Change175.22%
Month to Date Price Change$ 0.00
Month to Date Percent Change0.0%
Quarter to Date Price Change$ 0.00
Quarter to Date Percent Change0.0%
180 Day Price Change$ -4.83
180 Day Percent Change-70.72%
200 Day Price Change$ -6.38
200 Day Percent Change-76.13%
Year to Date Price Change$ -14.01
Year to Date Percent Change-87.51%

Spero Therapeutics Inc. (SPRO) Key Ratios

PROFITABILITY
EBIT Margin-628.7%
EBITDA Margin-624.0%
Pre-Tax Profit Margin-1,061.3%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 3,887,000
Revenue Per Share$ 0.1108
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book2.00
Total Debt To Equity0.20
Int Coverage-23.90
Current Ratio3.70
Leverage Ratio3.20
Quick Ratio3.30
Long Term Debt To Capital0.13
VALUATION MEASURES
PE Ratio-0.60
Enterprise Value$ 32,438,303
Price to Sales18.0435
Price to Free Cash-0.90
PE High Last 5 Years-1.00
Price To Book2.00
Price To Cash Flow0.00
PE Low Last 5 Years-3.30
Price to Tangible Book2.00
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.40
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-123.64
Return on Equity-179.55
Return on Capital-155.15

Spero Therapeutics Inc. (SPRO) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorPricewaterhouseCoopers LLP
CEOAnkit Mahadevia
Emplyoees41
Last AuditUE
CIK0001701108
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address675 Massachusetts Avenue
14th Floor
Cambridge, MA 2139
Websitehttps://www.sperotherapeutics.com
Facsimile-
Telephone+1 857 242-1600
EmailIR@sperotherapeutics.com
Your Recent History
NASDAQ
SPRO
Spero Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20221005 15:45:55